Darbepoetin-alfa in renal-transplant patients: An observational monocentric study

Clinical Nephrology

Volumn 69, Issue 2, 2008, Pages 102-106

  Ribes, D ^a   Kamar, N ^a   Guitard, J ^a   Esposito, L ^a   Rostaing, L ^a  

^a CHU RANGUEIL   (France)

Author keywords

Alfa; Anemia; Darbepoetin; Renal transplantation; Rrecombinant human erythropoietin

Indexed keywords

CREATININE; CYCLOSPORIN; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY HEMORRHAGE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; OBSERVATIONAL STUDY; VERRUCA VULGARIS;

EID: 38949195979     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69102     Document Type: Article

References (12)

1. Afzali B, Al-Khoury S, Shah N, Mikhail A, Covic A, Gold-Smith D. Anemia after renal transplantation. Am J Kidney Dis. 2006; 48: 519-536.
2. Aranesp® European summary of product characteristics (darbepoetin alfa). Amgen Breda. 2004; Netherlands.
3. Egrie JC, Browne JK. Development of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant. 2001; 16 (Suppl 3): 3-13.
4. El Haggan W, Vallet L. Hurault de Ligny B, et al. Darbepoetin alfa in the treatment of anemia in renal transplant patients: a single-center report. Transplantation. 2004; 77: 1914-1915.
5. Goshorn J, Youell TD. Darbepoetin alfa treatment for post-renal transplantation anemia during pregnancy. Am J Kidney Dis. 2005; 46: e81-86.
6. Jones M, Ibels L, Schenkel B, Zagari M. Impact of epoietin-alfa on clinical endpoints in patients with chronic renal failure: a meta-analysis. Kidney Int. 2004: 65: 757-767.
7. KDOQI National Kidney Foundation. IV Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis. 2006; 47 (Suppl 3): 109-116.
8. Lezaic V, Djukanovic L, Pavlovic-Kentera V. Recombinant human erythropoietin treatment of anemia in renal transplant patients. Ren Fail. 1995; 17: 705-714.
9. McDevitt LM, Smith LD, Somerville KT, Corbett JL, Shihab FS. A retrospective assessment of pre-treatment variables on the response to darbepoetin-alfa after renal transplantation. Am J Transplant. 2005; 5: 1948-1956.
10. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol. 2003; 14: 462-468.
11. Sezer S, Ozdemir FN, Tutal E, Bilgic A, Haberal M. Prevalence and etiology of anemia in renal transplant recipients. Transplant Proc. 2006; 38: 537-540.
12. Traindl O, Barnas U, Franz M et al. Recombinant human erythropoietin in renal transplant recipients with renal anemia. Clin Transplant. 1994; 8: 45-48.